Abstract
Background/Objectives:
Body mass index (BMI), waist circumference (WC), body weight modification, and rate of weight increase over 10 years were evaluated in relation to high-sensitive C-reactive protein (hs-CRP) to assess the association of cross-sectional or longitudinal estimates of obesity/overweight with levels of circulating CRP, a well established and standardized marker of low-grade inflammation, in relation to cardiovascular risk.
Subjects:
This study included a subgroup of 390 menopausal women participating in a large currently ongoing epidemiological study (Progetto Atena; N=5062).
Results:
At the final visit, women in the third tertile of BMI, compared with those in the first tertile, showed the following odds ratio (OR) of having high hs-CRP values: III vs I tertile OR, 3.55; 95% confidence interval, 1.94–6.49, P<0.001, adjusted for age, and metabolic syndrome. Similar results were obtained when we evaluated women in the third tertile of WC, or those in the highest group of estimated weight increase, relative to their weight at age 20 years or in the group of highest rate of weight increase over 10 years of observation (weight at the final visit−weight at the baseline visit divided by time in months between visits).
Conclusions:
The independent relations between different markers of overweight/obesity and elevated hs-CRP consistently indicate that high (above 1.5 mg l–1, median) hs-CRP is a major biochemical counterpart of cross-sectional or longitudinal estimates of increased adipose tissue mass.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barbagallo CM, Cavera G, Sapienza M, Noto D, Cefalù AB, Pagano M et al. (2001). Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality: the Ventimiglia di Sicilia project. Int J Obes Relat Metab Disord 25, 185–190.
Beer-Borst S, Morabia A, Hercberg S, Vitek O, Bernstein MS, Galan P et al. (2000). Obesity and other health determinants across Europe: the EURALIM project. J Epidemiol Community Health 54, 424–430.
Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC (1990). Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12, 1179–1186.
Devaraj S, Singh U, Jialal I (2009). Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 20, 182–189.
Fried SK, Bunkin DA, Greenberg AS (1998). Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83, 847–850.
Fry J, Finley W (2005). The prevalence and costs of obesity in the EU. Proc Nutr Soc 64, 359–362.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735–2752.
Haffner SM (2006). Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity 14, 121–127.
Haffner SM (2007). Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med 120, S10–S17.
Hamer M, Steptoe A (2009). Prospective study of physical fitness, adiposity, and inflammatory markers in healthy middle-aged men and women. Am J Clin Nutr 89, 85–89.
Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280, E745–E751.
Klipstein-Grobusch K, Georg T, Boeing H (1997). Interviewer variability in anthropometric measurements and estimates of body composition. Int J Epidemiol 26, S174–S180.
Koh KK, Han SH, Quon MJ (2005). Inflammatory markers and the metabolic syndrome. Insights from therapeutic interventions. J Am Coll Cardiol 46, 1978–1985.
Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977). Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 3, 882–884.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
Mohamed-Ali V, Pinkney JH, Coppack SW (1998). Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22, 1145–1158.
Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T et al. (2004). Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab 89, 2728–2735.
Oda E (2008). The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31, 1283–1291.
Okita K, Nishijima H, Murakami T, Nagai T, Morita N, Yonezawa K et al. (2004). Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 24, 868–873.
Panico S, Dello Iacovo R, Celentano E, Galasso R, Muti P, Salvatore M et al. (1992). Progetto Atena, a study on the etiology of major chronic diseases in women: design, rationale and objectives. Eur J Epidemiol 8, 601–608.
Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP (1998). The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128, 127–137.
Pérez Pérez A, Ybarra Muñoz J, Blay Cortés V, de Pablos Velasco P (2007). Obesity and cardiovascular disease. Public Health Nutr 10, 1156–1163.
Ridker PM (2007). Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 65, S253–S259.
Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS et al. (2007). Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. Am J Cardiol 100, 1659–1664.
Rosengren A, Wedel H, Wilhelmsen L (1999). Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 20, 269–277.
Scherer PE (2006). Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55, 1537–1545.
Selvin E, Paynter NP, Erlinger TP (2007). The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167, 31–39.
Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW (1981). Improved reagent for enzymatic determination of serum cholesterol. J Clin Chem Biochem 19, 838–839.
Wahlefeld AW (1974). Triglyceride determination after enzymatic hydrolysis, Bergmeyer HU (ed). Methods of Enzymatic Analysis. Academic Press: New York. vol. 4, 2nd edn 1831.
Walker M, Wannamethee G, Whincup PH, Shaper AG (1995). Weight change and risk of heart attack in middle-aged British men. Int J Epidemiol 24, 694–703.
Wannamethee SG, Shaper AG (1999). Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22, 1266–1272.
Wannamethee SG, Shaper AG, Walker M (2005). Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health 59, 134–139.
Acknowledgements
This study was supported by funds from MIUR 2001 no. 068937 and 2004 no. 065985.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Gentile, M., Panico, S., Rubba, F. et al. Obesity, overweight, and weight gain over adult life are main determinants of elevated hs-CRP in a cohort of Mediterranean women. Eur J Clin Nutr 64, 873–878 (2010). https://doi.org/10.1038/ejcn.2010.69
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.69
Keywords
This article is cited by
-
Comparative study evaluating antihistamine versus leukotriene receptor antagonist as adjuvant therapy for rheumatoid arthritis
European Journal of Clinical Pharmacology (2021)
-
Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation
Journal of Endocrinological Investigation (2019)
-
Maternal pregnancy weight gain and cord blood iron status are associated with eosinophilia in infancy
Journal of Perinatology (2015)
-
Neonatal iron status is impaired by maternal obesity and excessive weight gain during pregnancy
Journal of Perinatology (2014)
-
Sexual Orientation and Gender Differences in Markers of Inflammation and Immune Functioning
Annals of Behavioral Medicine (2014)